We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$406M
AUM Growth
-$32.3M
Cap. Flow
-$132M
Cap. Flow %
-32.56%
Top 10 Hldgs %
49.27%
Holding
151
New
39
Increased
19
Reduced
25
Closed
51

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$31.3M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$19.6M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.25M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$6.43M
5
AGN
Allergan Inc
AGN
+$6.23M

Top Sells

Rank Stock Value
1
SMMF
Summit Financial Group, Inc.
SMMF
+$116M
2
GSK icon
GSK
GSK
+$19M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$15.2M
4
LLY icon
Eli Lilly
LLY
+$11.9M
5
SNY icon
Sanofi
SNY
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 73.98%
2 Technology 4.07%
3 Consumer Discretionary 3.5%
4 Industrials 2.92%
5 Communication Services 1.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVS icon
1
Novartis
NVS
$297B
$48.3M 11.9%
594,940
-2,232
-0.4% -$176K
MRK icon
2
Merck
MRK
$322B
$24.9M 6.13%
450,640
-104,800
-19% -$5.72M
TEVA icon
3
Teva Pharmaceuticals
TEVA
$40.8B
$23.3M 5.74%
444,500
+382,900
+622% +$19.6M
JNJ icon
4
Johnson & Johnson
JNJ
$618B
$22.3M 5.51%
213,600
-10,000
-4% -$1.01M
PFE icon
5
Pfizer
PFE
$143B
$19.4M 4.79%
689,944
-210,800
-23% -$6.01M
GSK icon
6
GSK
GSK
$104B
$16M 3.95%
240,000
-280,000
-54% -$19M
SHPG
7
DELISTED
Shire pic
SHPG
$14.1M 3.47%
+180,000
New +$31.3M
SNY icon
8
Sanofi
SNY
$103B
$12.7M 3.14%
120,000
-200,000
-63% -$10.6M
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
$11.4M 2.81%
297,800
+170,000
+133% +$6.43M
BMRN icon
10
BioMarin Pharmaceuticals
BMRN
$11.6B
$7.46M 1.84%
+120,000
New +$7.25M
BIIB icon
11
Biogen
BIIB
$30B
$6.94M 1.71%
22,000
+5,000
+29% +$1.5M
AGN
12
DELISTED
Allergan Inc
AGN
$6.77M 1.67%
+40,000
New +$6.23M
VRNT
13
DELISTED
Verint Systems
VRNT
$6.6M 1.63%
+264,122
New +$6.21M
DYAX
14
DELISTED
DYAX CORPORATION
DYAX
$6.24M 1.54%
+650,000
New +$4.95M
LLY icon
15
Eli Lilly
LLY
$1.02T
$6.22M 1.53%
100,000
-200,000
-67% -$11.9M
AVNR
16
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$5.64M 1.39%
+1,000,000
New +$4.61M
MDVN
17
DELISTED
MEDIVATION, INC.
MDVN
$5.4M 1.33%
+140,000
New +$4.72M
ORBK
18
DELISTED
Orbotech Ltd
ORBK
$5.22M 1.29%
343,602
+120,428
+54% +$1.81M
ACOR
19
DELISTED
Acorda Therapeutics
ACOR
$5.06M 1.25%
+1,250
New +$5.1M
GOOG icon
20
Alphabet (Google) Class C
GOOG
$4.36T
$4.82M 1.19%
166,937
+51,948
+45% +$1.41M
AMGN icon
21
Amgen
AMGN
$208B
$4.74M 1.17%
40,000
-30,000
-43% -$3.47M
BCOM
22
DELISTED
B Communications Ltd
BCOM
$4.71M 1.16%
+241,705
New +$4.37M
YUM icon
23
Yum! Brands
YUM
$42.2B
$4.58M 1.13%
+78,498
New +$4.37M
CSX icon
24
CSX Corp
CSX
$93.4B
$4.57M 1.13%
444,975
+94,500
+27% +$920K
WBA
25
DELISTED
Walgreens Boots Alliance
WBA
$4.52M 1.11%
60,993
+9,540
+19% +$666K
1
2 3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Sphera Funds Management held 151 positions worth $406M, down 7.4% from $438M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sphera Funds Management withdrew a net $132M in Q2 2014, closing 51 positions and reducing 25 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 74% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Shire pic worth $14.1M.

  • Sphera Funds Management's largest Q2 2014 buy was Shire pic: 180,000 shares worth $14.1M.
  • Sphera Funds Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $19.6M increase.
  • Sphera Funds Management's biggest Q2 2014 reduction was Summit Financial Group, Inc., cutting an estimated $116M.
  • Sphera Funds Management fully exited State Street Financial Select Sector SPDR ETF in Q2 2014, selling an estimated $15.2M.
  • Sphera Funds Management's ten largest holdings make up 49% of its $406M portfolio in Q2 2014.
  • Sphera Funds Management opened 39 new positions and closed 51 in Q2 2014.
  • Sphera Funds Management's portfolio value fell 7.4% quarter-over-quarter to $406M.

Based on Sphera Funds Management's 13F filing for Q2 2014, filed 11 Aug 2014.